Evidence map›Paper›PMID 37844949›Full record

ArticleNeurosciences (Riyadh, Saudi Arabia)2023

Reccurent guillain barré syndrome after COVID-19.

Svetlana D Miletic Drakulic, Snezana R Lazarevic, Ivana P Miloradovic, Vladimir S Jankovic

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurosciences (Riyadh, Saudi Arabia), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Svetlana D Miletic DrakulicFrom the Department of Neurology, Faculty of Medical Sciences, University of Kragujevac,Kragujevac, Serbia.
Snezana R LazarevicFrom the Department of Neurology, Faculty of Medical Sciences, University of Kragujevac,Kragujevac, Serbia.
Ivana P MiloradovicFrom the Department of Neurology, Faculty of Medical Sciences, University of Kragujevac,Kragujevac, Serbia.
Vladimir S JankovicFrom the Department of Neurology, Faculty of Medical Sciences, University of Kragujevac,Kragujevac, Serbia.ORCID https://orcid.org/0000-0002-6758-7606
University of Kragujevac · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 19 (COVID-19) is known to manifest itself predominantly with respiratory symptoms. However, previous experiences with this disease and many scientific studies have drawn attention to its neurological manifestations. The link between COVID-19 and many neurological diseases, including Guillain Barré syndrome (GBS), has been pointed out. Although GBS is considered a monophasic disease, its relapses occur in 2-6% of cases. We present the case of a female patient with recurrent GBS caused by COVID-19. Given that 2-6% of patients experience a relapse of GBS, and that the COVID-19 pandemic is recognized as a possible trigger of the relapse, we emphasize the importance of intensive neurological monitoring for patients diagnosed with COVID-19 who have a history of GBS.

Indexed as

COVID-19Guillain-Barre SyndromeFemaleHumansPandemicsRecurrence

Identifiers

PMID37844949
PMCPMC10827027
OpenAlexW4387675066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.